Skip to main content
Top
Published in: Sleep and Breathing 2/2021

01-06-2021 | Sleep Apnea | Neurology • Original Article

Diagnosing narcolepsy in the active duty military population

Authors: Bernadette Villarreal, Tyler Powell, Matthew S. Brock, Shana Hansen

Published in: Sleep and Breathing | Issue 2/2021

Login to get access

Abstract

Purpose

Narcolepsy type I and type II are central hypersomnias characterized by excessive daytime sleepiness and nocturnal sleep disruptions. These rare disorders make the diagnosis complex, as multiple sleep disorders are known to cause false-positive results on testing. There is a high incidence of sleep disorders in the military, and the diagnosis of narcolepsy can have serious career implications. This study looked to assess for the presence of confounding disorders in patients previously diagnosed with narcolepsy.

Methods

We conducted a retrospective analysis of patients aged 18–65 previously diagnosed with narcolepsy at an outside facility, referred for repeat evaluation at the Wilford Hall Sleep Disorders Center. Previous test results from the time of original diagnosis were reviewed if available and compared with repeat evaluation which included actigraphy, in-laboratory polysomnography, and multiple sleep latency testing.

Results

Of the 23 patients, 2 (9%) retained a diagnosis of narcolepsy after repeat testing. Ten patients (43%) had insufficient sleep syndrome, five (22%) had significant circadian rhythm sleep-wake disorders, and nine (39%) patients were diagnosed with mild obstructive sleep apnea (OSA). Four of the nine patients with OSA (44%) had supine predominant OSA.

Conclusion

Diagnostic testing for narcolepsy may be influenced by the presence of comorbid sleep disorders including sleep-disordered breathing, insufficient sleep duration, and circadian misalignment which are common in active military personnel. This study emphasizes the importance of excluding these comorbid diagnoses in this population.
Literature
3.
go back to reference American Academy of Sleep Medicine (2014) International Classification of Sleep Disorders, 3rd edn. American Academy of Sleep Medicine, Darien American Academy of Sleep Medicine (2014) International Classification of Sleep Disorders, 3rd edn. American Academy of Sleep Medicine, Darien
11.
go back to reference Aldrich M, Chervin R, Malow B (1997) Value of the multiple sleep latency test (MSLT) for the diagnosis of narcolepsy. Sleep 20:620–629PubMed Aldrich M, Chervin R, Malow B (1997) Value of the multiple sleep latency test (MSLT) for the diagnosis of narcolepsy. Sleep 20:620–629PubMed
33.
go back to reference Letteri C, Eliasson A, Andrada T, Khramtsov A, Raphaelson M, Kristo D (2005) Obstructive sleep apnea syndrome: are we missing an at-risk population? J Clin Sleep Med 1:381–385CrossRef Letteri C, Eliasson A, Andrada T, Khramtsov A, Raphaelson M, Kristo D (2005) Obstructive sleep apnea syndrome: are we missing an at-risk population? J Clin Sleep Med 1:381–385CrossRef
Metadata
Title
Diagnosing narcolepsy in the active duty military population
Authors
Bernadette Villarreal
Tyler Powell
Matthew S. Brock
Shana Hansen
Publication date
01-06-2021
Publisher
Springer International Publishing
Published in
Sleep and Breathing / Issue 2/2021
Print ISSN: 1520-9512
Electronic ISSN: 1522-1709
DOI
https://doi.org/10.1007/s11325-020-02163-5

Other articles of this Issue 2/2021

Sleep and Breathing 2/2021 Go to the issue

Sleep Breathing Physiology and Disorders • Original Article

The role of antioxidant vitamins and selenium in patients with obstructive sleep apnea

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.